Reflections on the tissue kallikrein and kallikrein-related peptidase family - From mice to men - What have we learnt in the last two decades?

Biological Chemistry

Volumn 389, Issue 12, 2008, Pages 1447-1454

  Clements, Judith A ^a  

^a QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

Author keywords

Expression; Function; Gene clusters; Glandular kallikrein (GK); Hormonal regulation; Kallikrein related (KLK)

Indexed keywords

SERINE PROTEINASE; TISSUE KALLIKREIN;

GENE CLUSTER; GENE EXPRESSION; GENE LOCUS; HORMONAL REGULATION; HUMAN; MULTIGENE FAMILY; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW;

ANIMALS; GENE EXPRESSION REGULATION; HUMANS; MICE; PEPTIDE HYDROLASES; TISSUE KALLIKREINS;

MUS; RODENTIA;

EID: 57649112534     PISSN: 14316730     EISSN: 14374315     Source Type: Journal    
DOI: 10.1515/BC.2008.174     Document Type: Review

References (72)

1. Ahn, J., Berndt, S.I., Wacholder, S., Kraft, P., Kibel, A.S., Yeager, M., Albanes, D., Giovannucci, E., Stampfer, M.J., Virtamo, J., et al. (2008). Variation in KLK genes, prostate-specific antigen and risk of prostate cancer. Nat. Genet. 40, 1032-1034.
2. Bax, B., Blaber, M., Ferguson, G., Sternberg, M.J, and Walls, P.H. (1993). Prediction of the three-dimensional structures of the nerve growth factor and epidermal growth factor binding proteins (kallikreins) and an hypothetical structure of the high molecular weight complex of epidermal growth factor with its binding protein. Protein Sci. 2, 1229-1241.
3. Berg, T., Bradshaw, R.A., Carretero, O.A., Chao, J., Chao, L., Clements, J.A. Fahnestock, M., Fritz, H., Gauthier, F., MacDonald, R.J., et al. (1992). A common nomenclature for members of the tissue (glandular) kallikrein gene families. Agents Actions (Suppl.) 38, 19-25.
4. Bernett, M.J., Blaber, S.I., Scarisbrick, I.A., Dhanarajan, P., Thompson, S.M., and Blaber, M. (2002). Crystal structure and biochemical characterization of human kallikrein 6 reveals that a trypsin-like kallikrein is expressed in the central nervous system. J. Biol. Chem. 277, 24562-24570.
5. Bhoola, K.D., Figueroa, C.D., and Worthy, K. (1992). Bioregulation of kinins: kallikreins, kininogens, and kininases. Pharmacol. Rev. 44, 1-80.
6. Bode, W., Chen, Z., Bartels, K., Kutzbach, C., Schmidt-Kastner, G., and Bartunik, H. (1983). Refined 2 Å X-ray crystal structure of porcine pancreatic kallikrein A, a specific trypsin-like serine proteinase. Crystallization, structure determination, crystallographic refinement, structure and its comparison with bovine trypsin. J. Mol. Biol. 164, 237-282.
7. Borgoño, C.A. and Diamandis, E.P. (2004). The emerging roles of human tissue kallikreins in cancer. Nat. Rev. Cancer 4, 876-890.
8. Borgoño, C.A., Gavigan, J.A., Alves, J., Bowles, B., Harris, J.L., Sotiropoulou, G., and Diamandis, E.P. (2007). Defining the extended substrate specificity of kallikrein 1-related peptidases. Biol. Chem. 388, 1215-1225.
9. Clements, J.A. (1989). The glandular kallikrein family of enzymes: tissue-specific expression and hormonal regulation. Endocr. Rev. 10, 393-419.
10. Clements, J.A. (1997). The molecular biology of the kallikreins and their roles in inflammation. In: The Kinin System, S. Farmer, ed. (New York, USA: Academic Press, Inc.), pp. 71-97.
11. Clements, J.A. (2000). Tissue kallikrein-kinin system. In: Endocrine Regulation of Electrolyte and Water Balance, Section 7: The Endocrine System, Handbook of Physiology, Vol. III, J.C.S. Fray, ed. (New York, USA: Oxford University Press), pp. 333-376.
12. Clements, J.A. and Fuller, P. (1990). Tissue kallikrein in the pituitary and brain. Front. Neuroendocrinol. 1, 38-51.
13. Clements, J.A., Matheson, B.A., Wines, D.R., Brady, J.M., MacDonald, R.J., and Funder, J.W. (1988). Androgen dependence of specific kallikrein gene family members expressed in rat prostate. J. Biol. Chem. 263, 16132-16137.
14. Clements, J.A., Willemsen, N.M., Myers, M., and Dong, Y. (2004). The tissue kallikrein family of serine proteases: functional roles in human disease and potential as clinical biomarkers. Crit. Rev. Clin. Lab. Sci. 41, 265-312.
15. Cleutjens, K.B., an der Korput, H.A., Ehren-van Eekelen, C.C., Sikes, R.A. Fasciana, C., Chung, L.W., and Trapman, J. (1997). A 6-kb promoter fragment mimics in transgenic mice the prostate-specific and androgen-regulated expression of the endogenous prostate-specific antigen gene in humans. Mol. Endocrinol. 11, 1256-1265.
16. Cloutier, S.M., Chagas, J.R., Mach, J.P., Gygi, C.M., Leisinger, H.J., and Deperthes, D. (2002). Substrate specificity of human kallikrein 2 (hK2) as determined by phage display technology. Eur. J. Biochem. 269, 2747-2754.
17. Costa-Neto, C.M., Dillenburg-Pilla, P., Heinrich, T.A., Parreiras-e-Silva, L.T., Pereira, M.G., Reis, R.I., and Souza, P.P. (2008). Participation of kallikrein-kinin system in different pathologies. Int. Immunopharmacol. 8, 135-142.
18. Debela, M., Magdolen, V., Grimminger, V., Sommerhoff, C., Messerschmidt, A., Huber, R., Friedrich, R., Bode, W., and Goettig, P. (2006a). Crystal structures of human tissue kallikrein 4: activity modulation by a specific zinc binding site. J. Mol. Biol. 362, 1094-1107.
19. Debela, M., Magdolen, V., Schechter, N., Valachova, M., Lottspeich, F., Craik, C.S., Choe, Y., Bode, W., and Goettig, P. (2006b). Specificity profiling of seven human tissue kallikreins reveals individual subsite preferences. J. Biol. Chem. 281, 25678-25688.
20. Debela, M., Goettig, P., Magdolen, V., Huber, R., Schechter, N.M., and Bode, W. (2007a). Structural basis of the zinc inhibition of human tissue kallikrein 5. J. Mol. Biol. 373, 1017-1031.
21. Debela, M., Hess, P., Magdolen, V., Schechter, N.M., Steiner, T., Huber, R., Bode, W., and Goettig, P. (2007b). Chymotryptic specificity determinants in the 1.0 Å structure of the zinc-inhibited human tissue kallikrein 7. Proc. Natl. Acad. Sci. USA 104, 16086-16091.
22. Descargues, P., Deraison, C., Bonnart, C., Kreft, M., Kishibe, M., Ishida-Yamamoto, A., Elias, P., Barrandon, Y., Zambruno, G., Sonnenberg, A., and Hovnanian, A. (2005). Spink5-deficient mice mimic Netherton syndrome through degradation of desmoglein 1 by epidermal protease hyperactivity. Nat. Genet. 37, 56-65.
23. Diamandis, E.P., Yousef, G.M., Clements, J., Ashworth, L.K., Yoshida, S., Egelrud, T., Nelson, P.S., Shiosaka, S., Little, S., Lilja, H., et al. (2000). New nomenclature for the human tissue kallikrein gene family. Clin. Chem. 46, 1855-1858.
24. Dong, Y., Bui, L.T., Odorico, D.M., Tan, O.L., Myers, S.A., Samaratunga, H., Gardiner, R.A., and Clements, J.A. (2005). Compartmentalized expression of kallikrein 4 (KLK4/hK4) isoforms in prostate cancer: nuclear, cytoplasmic and secreted forms. Endocr. Relat. Cancer 12, 875-889.
25. Eeles, R.A., Kote-Jarai, Z., Giles, G.G., Olama, A.A., Guy, M., Jugurnauth, S.K., Mulholland, S., Leongamornlert, D.A., Edwards, S.M., Morrison, J., et al. (2008). Multiple newly identified loci associated with prostate cancer susceptibility. Nat. Genet. 40, 316-321.
26. Evans, B.A., Drinkwater, C.C., and Richards, R.I. (1987). Mouse glandular kallikrein genes. Structure and partial sequence analysis of the kallikrein gene locus. J. Biol. Chem. 262, 8027-8034.
27. Felber, L.M., Borgoño, C.A., Cloutier, S.M., Kündig, C., Kishi, T., Ribeiro Chagas, J., Jichlinski, P., Gygi, C.M., Leisinger, H.J., Diamandis, E.P., and Deperthes, D. (2005). Enzymatic profiling of human kallikrein 14 using phage-display substrate technology. Biol. Chem. 386, 291-298.
28. Fujinaga, M. and James, M.N. (1987). Rat submaxillary gland serine protease, tonin. Structure solution and refinement at 1.8 Å resolution. J. Mol. Biol. 195, 373-396.
29. Gan, L., Lee, I., Smith, R., Argonza-Barrett, R., Lei, H., McCuaig, J., Moss, P., Paeper, B., and Wang, K. (2000). Sequencing and expression analysis of the serine protease gene cluster located in chromosome 19q13 region. Gene 257, 119-130.
30. Gomis-Ruth, F.X., Bayes, A., Sotiropoulou, G., Pampalakis, G., Tsetsenis, T., Villegas, V., Aviles, F.X., and Coll, M. (2002). The structure of human prokallikrein 6 reveals a novel activation mechanism for the kallikrein family. J. Biol. Chem. 277, 27273-27281.
31. Harvey, T.J., Hooper, J.D., Myers, S.A., Stephenson, S.A., Ashworth, L.K., and Clements, J.A. (2000). Tissue-specific expression patterns and fine mapping of the human kallikrein (KLK) locus on proximal 19q13.4. J. Biol. Chem. 275, 37397-37406.
32. Hecquet, C., Becker, R.P., Tan, F., and Erdos, E.G. (2002). Kallikreins when activating bradykinin B2 receptor induce its redistribution on plasma membrane. Int. Immunopharmacol. 2, 1795-1806.
33. Heidtmann, H.H., Nettelbeck, D.M., Mingels, A., Jager, R., Welker, H.G., and Kontermann, R.E. (1999). Generation of angiostatin-like fragments from plasminogen by prostate-specific antigen. Br. J. Cancer 81, 1269-1273.
34. Hu, J.C., Chun, Y.H., Al Hazzazzi, T., and Simmer, J.P. (2007). Enamel formation and amelogenesis imperfecta. Cells Tissues Organs 186, 78-85.
35. Kaushal, A., Myers, S.A., Dong, Y., Lai, J., Tan, O.L., Bui, L.T., Hunt, M.L., Digby, M.R., Samaratunga, H., Gardiner, R.A., et al. (2008). A novel transcript from the KLKP1 gene is androgen regulated, down-regulated during prostate cancer progression and encodes the first non-serine protease identified from the human kallikrein gene locus. Prostate 68, 381-399.
36. Kishi, T., Kato, M., Shimizu, T., Kato, K., Matsumoto, K., Yoshida, S., Shiosaka, S., and Hakoshima, T. (1999). Crystal structure of neuropsin, a hippocampal protease involved in kindling epileptogenesis. J. Biol. Chem. 274, 4220-4224.
37. Kishibe, M., Bando, Y., Terayama, R., Namikawa, K., Takahashi, H., Hashimoto, Y., Ishida-Yamamoto, A., Jiang, Y.P., Mitrovic, B., Perez, D., et al. (2007). Kallikrein 8 is involved in skin desquamation in cooperation with other kallikreins. J. Biol. Chem. 282, 5834-5841.
38. Kroon, E., MacDonald, R.J., and Hammer, R.E. (1997). The transcriptional regulatory strategy of the rat tissue kallikrein gene family. Genes Funct. 1, 309-319.
39. Kumar, A., Mikolajczyk, S.D., Hill, T.M., Millar, L.S., and Saedi, M.S. (2000). Different proportions of various prostate-specific antigen (PSA) and human kallikrein 2 (hK2) forms are present in noninduced and androgen-induced LNCaP cells. Prostate 44, 248-254.
40. Kurlender, L., Borgono, C., Michael, I.P., Obiezu, C., Yousef, G.M., and Diamandis, E.P. (2005). A survey of alternative transcripts of human tissue kallikrein genes. Biochim. Biophys. Acta 1755, 1-14.
41. Lai, J., Kedda, M.A., Hinze, K., Smith, R.L., Yaxley, J., Spurdle, A.B., Morris, C.P., Harris, J., and Clements, J.A. (2007). PSA/KLK3 AREI promoter polymorphism alters androgen receptor binding and is associated with prostate cancer susceptibility. Carcinogenesis 28, 1032-1039.
42. Lai, J., Myers, S.A., Lawrence, M.G., Odorico, D.M., and Clements, J.A. (2008). Direct progesterone receptor and indirect androgen receptor interactions with the kallikrein-related peptidase 4 gene promoter in breast and prostate cancer. Mol. Cancer Res., in press.
43. Laxmikanthan, G., Blaber, S.I., Bernett, M.J., Scarisbrick, I.A., Juliano, M.A., and Blaber, M. (2005). 1.70 Å X-ray structure of human apo kallikrein 1: structural changes upon peptide inhibitor/substrate binding. Proteins 58, 802-814.
44. Lilja, H., Ulmert, D., and Vickers, A.J. (2008). Prostate-specific antigen and prostate cancer: prediction, detection and monitoring. Nat. Rev. Cancer 8, 268-278.
45. Lundwall, A. and Brattsand, M. (2008). Kallikrein-related peptidases. Cell Mol. Life Sci. 65, 2019-2038.
46. Lundwall, A., Band, V., Blaber, M., Clements, J.A., Courty, Y., Diamandis, E.P., Fritz, H., Lilja, H., Malm, J., Maltais, L.J., et al. (2006). A comprehensive nomenclature for serine proteases with homology to tissue kallikreins. Biol. Chem. 387, 637-641.
47. MacDonald, R.J., Southard-Smith, E.M., and Kroon, E. (1996). Disparate tissue-specific expression of members of the tissue kallikrein multigene family of the rat. J. Biol. Chem. 271, 13684-13690.
48. Matsumura, M., Bhatt, A.S., Andress, D., Clegg, N., Takayama, T.K., Craik C.S., and Nelson, P.S. (2005). Substrates of the prostate-specific serine protease prostase/KLK4 defined by positional-scanning peptide libraries. Prostate 62, 1-13.
49. Ménez, R., Michel, S., Muller, B.H., Bossus, M., Ducancel, F., Jolivet-Reynaud, C., and Stura, E.A. (2008). Crystal structure of a ternary complex between human prostate-specific antigen, its substrate acyl intermediate and an activating antibody. J. Mol. Biol. 376, 1021-1033.
50. Nelson, P.S., Gan, L., Ferguson, C., Moss, P., Gelinas, R., Hood, L., and Wang, K. (1999). Molecular cloning and characterization of prostase, an androgen-regulated serine protease with prostate-restricted expression. Proc. Natl. Acad. Sci. USA 96, 3114-3119.
51. Oikonomopoulou, K., Hansen, K.K., Saifeddine, M., Tea, I., Blaber, M., Blaber, S.I., Scarisbrick, I., Andrade-Gordon, P., Cottrell, G.S., Bunnett, N.W., et al. (2006). Proteinase-activated receptors, targets for kallikrein signaling. J. Biol. Chem. 281, 32095-32112.
52. Olsson, A.Y. and Lundwall, A. (2002). Organization and evolution of the glandular kallikrein locus in Mus musculus. Biochem. Biophys. Res. Commun. 299, 305-311.
53. Pal, P., Xi, H., Sun, G., Kaushal, R., Meeks, J.J., Thaxton, C.S., Guha, S., Jin, C.H., Suarez, B.K., Catalona, W.J., and Deka, R. (2007). Tagging SNPs in the kallikrein genes 3 and 2 on 19q13 and their associations with prostate cancer in men of European origin. Hum. Genet. 122, 251-259.
54. Paliouras, M. and Diamandis, E.P. (2006). The kallikrein world: an update on the human tissue kallikreins. Biol. Chem. 387, 643-652.
55. Pampalakis, G. and Sotiropoulou, G. (2007). Tissue kallikrein proteolytic cascade pathways in normal physiology and cancer. Biochim. Biophys. Acta 1776, 22-31.
56. Picard, N., Eladari, D., El Moghrabi, S., Planes, C., Bourgeois, S., Houillier, P., Wang, Q., Burnier, M., Deschenes, G., Knepper, M.A., et al. (2008). Defective ENaC processing and function in tissue kallikrein-deficient mice. J. Biol. Chem. 283, 4602-4611.
57. Powers, C.A. and Hatala, M.A. (1986). Dopaminergic regulation of the estrogen-induced glandular kallikrein in the rat anterior pituitary. Neuroendocrinology 44, 462-469.
58. Ramsay, A.J., Dong, Y., Hunt, M.L., Linn, M., Samaratunga, H., Clements, J.A., and Hooper, J.D. (2008). Kallikrein-related peptidase 4 (KLK4) initiates intracellular signaling via protease-activated receptors (PARs): KLK4 and PAR-2 are coexpressed during prostate cancer progression. J. Biol. Chem. 283, 12293-12304.
59. Riegman, P.H., Vlietstra, R.J., Klaassen, P., van der Korput, J.A., Geurts van Kessel, A., Romijn, J.C., and Trapman, J. (1989). The prostate-specific antigen gene and the human glandular kallikrein-1 gene are tandemly located on chromosome 19. FEBS Lett. 247, 123-126.
60. Shaw, J.L. and Diamandis, E.P. (2007). Distribution of 15 human kallikreins in tissues and biological fluids. Clin. Chem. 53, 1423-1432.
61. Sotiropoulou, G., Rogakos, V., Tsetsenis, T., Pampalakis, G., Zafiropoulos, N., Simillides, G., Yiotakis, A., and Diamandis, E.P. (2003). Emerging interest in the kallikrein gene family for understanding and diagnosing cancer. Oncol. Res. 13, 381-391.
62. Takayama, T.K., Fujikawa, K., and Davie, E.W. (1997). Characterization of the precursor of prostate-specific antigen. Activation by trypsin and by human glandular kallikrein. J. Biol. Chem. 272, 21582-21588.
63. Tan, O.L., Whitbread, A.K., Clements, J.A., and Dong, Y. (2006). Kallikrein-related peptidase (KLK) family mRNA variants and protein isoforms in hormone-related cancers: do they have a function? Biol. Chem. 387, 697-705.
64. Terayama, R., Bando, Y., Murakami, K., Kato, K., Kishibe, M., and Yoshida, S. (2007). Neuropsin promotes oligodendrocyte death, demyelination and axonal degeneration after spinal cord injury. Neuroscience 148, 175-187.
65. Timm, D.E. (1997). The crystal structure of the mouse glandular kallikrein-13 (prorenin converting enzyme). Protein Sci. 6, 1418-1425.
66. van Leeuwen, B.H., Penschow, J.D., Coghlan, J.P., and Richards, R.I. (1987). Cellular basis for the differential response of mouse kallikrein genes to hormonal induction. EMBO J. 6, 1705-1713.
67. Wines, D.R., Brady, J.M., Southard, E.M., and MacDonald, R.J. (1991). Evolution of the rat kallikrein gene family: gene conversion leads to functional diversity. J. Mol. Evol. 32, 476-492.
68. Xi, Z., Klokk, T.I., Korkmaz, K., Kurys, P., Elbi, C., Risberg, B., Danielsen, H., Loda, M., and Saatcioglu, F. (2004). Kallikrein 4 is a predominantly nuclear protein and is overexpressed in prostate cancer. Cancer Res. 64, 2365-2370.
69. Yoon, H., Laxmikanthan, G., Lee, J., Blaber, S.I., Rodriguez, A., Kogot, J.M., Scarisbrick, I.A., and Blaber, M. (2007). Activation profiles and regulatory cascades of the human kallikrein-related peptidases. J. Biol. Chem. 282, 31852-31864.
70. Yousef, G.M. and Diamandis, E.P. (2001). The new human tissue kallikrein gene family: structure, function, and association to disease. Endocr. Rev. 22, 184-204.
71. Yousef, G.M., Luo, L.Y., and Diamandis, E.P. (1999). Identification of novel human kallikrein-like genes on chromosome 19q13.3-q13.4. Anticancer Res. 19, 2843-2852.
72. Yousef, G.M., Obiezu, C.V., Luo, L.Y., Magklara, A., Borgoño, C.A., Kishi, T., Memari, N., Michael, P., Sidiropoulos, M., Kurlender, L., et al. (2005) Human tissue kallikreins: from gene structure to function and clinical applications. Adv. Clin. Chem. 39, 11-79.